AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.
AquaBounty Technologies Announces Expansion of Strategic Alternatives Review to Include Power Infrastructure Development Opportunities
AquaBounty is expanding its strategic review of the Pioneer, Ohio property to include opportunities in power infrastructure and energy development, aiming to maximize shareholder value.
The site offers access to approximately 50 megawatts of electrical capacity and a permit to withdraw 5.25 million gallons per day of groundwater, assets management believes are attractive for data centers and energy-intensive industries.
The company plans to engage with developers and utilities regarding potential sales, joint ventures, or leases, though there is no assurance a transaction will occur.